Enlicitide chloride is a macrocyclic peptide compound being investigated as an orally available inhibitor of PCSK9 for the management of hypercholesterolaemia. It is supplied as a pharmaceutical raw material for research and manufacturing purposes.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2407527-16-4
(alphaS)-5,6,7,8-Tetrahydro-alpha-[[(tetrahydro-4-methyl-2H-pyran-4-yl)carbonyl]amino]-1,8-naphthyridine-2-nonanoic acid
active pharmaceutical ingredient
N-Benzyl albuterol
active pharmaceutical ingredient
7-Ketoabiraterone acetate
pharmaceutical impurity reference standard
FLUPENTIXOL DIHYDROCHLORIDE
Active pharmaceutical ingredient for schizophrenia
[6-[[(11S,17S,20S,23S,27S,39S,42S,63S,66R)-47-fluoro-20-[(1R)-1-hydroxyethyl]-17-[(4-methoxyphenyl)methyl]-11,63-dimethyl-10,16,19,22,30,40,58,61,64,67,70-undecaoxo-28-oxa-1,9,15,18,21,24,31,41,51,62,65,68-dodecazanonacyclo[37.18.11.23,6.124,42.133,37.144,51.011,15.023,27.045,50]triheptaconta-3(73),4,6(72),33,35,37(71),44(69),45(50),46,48-decaen-66-yl]methylamino]-6-oxohexyl]-trimethylazanium chloride
CLOLWQCFULXMAR-QQCDJELVSA-N
C[C@H]1C(=O)N[C@@H](C(=O)N[C@H]2CC3=CC(=CC=C3)CNC(=O)CO[C@H]4CCN5[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N6CCC[C@]6(C(=O)NCCC7=CC=C(CN(CCCCCCN8C=C(C[C@@H](C5=O)NC2=O)C9=C8C=CC(=C9)F)C(=O)CCC(=O)N1)C=C7)C)CC1=CC=C(C=C1)OC)[C@@H](C)O)CNC(=O)CCCCC[N+](C)(C)C.[Cl-]